Plakous Therapeutics receives research funding from Durham-based Altis Biosystems, will use Altis technology in new research

Winston-Salem regenerative medicine company Plakous Therapeutics has received a research grant from Durham-based biotechnology company Altis Biosystems. It will also use Altis' technology RepliGut in its research as it prepares for a new drug filing.